Trump Administration Injects $150M into xLight
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.XLIGHT STAKE:The Trump administration has agreed to inject up to $150M into xLight, which makes lasers for EUV machines and has former IntelCEO Pat Gelsinger on its board, for an equity stake, The Wall Street Journal's Amrith Ramkumar and Robbie Whelan. ASMLis currently the only global producer of EUV machines, which can cost hundreds of millions of dollars each.AMICABLE SETTLEMENT:Trump Media and Technologyannounced that Trump Media and United Atlantic Ventures reached an "amicable" settlement of their dispute and all claims by Trump Media against United Atlantic Ventures have been mutually resolved.NEW DOD AWARD:Immuronannounced a new research agreement with the Naval Medical Research Command -NMRC - and the Walter Reed Army Institute of Research, or WRAIR, Silver Spring, MD, USA funded by a U.S. Department of Defense subaward.The Naval Medical Research Command and the Walter Reed Army Institute of Research, in collaboration with Immuron, are progressing the development of novel vaccines targeting Campylobacter jejuni and Shigella sonnei. Under a recently executed collaborative research agreement with the Henry M. Jackson Foundation, new vaccine preparations against these pathogens have been developed and formulated at the military research institutes and subsequently provided to Immuron.Immuron will produce two hyper-immune bovine colostrum products for pre-clinical evaluation, with the objective of advancing a combined colostrum-based therapeutic specifically designed for the U.S. military. Also, the Uniformed Services University topline results from its clinical trial evaluating the effectiveness of enterotoxigenic E. coli hyperimmune bovine colostrum in maintaining gut health during deployment and travel are anticipated to be announced at the end of next week. In P2TD study, IMM-124E - the active ingredient in Travelan - was delivered in 600 mg powder sachets and administered twice daily in a randomized, placebo-controlled trial.Infectious diarrhea is the most common illness reported by travelers visiting developing countries and among U.S. troops deployed overseas. In the last decade, several enteric pathogens have an increasing resistance to commonly prescribed antibiotics.
Trade with 70% Backtested Accuracy
Analyst Views on INTC
About INTC
About the author

- IPO Filing: California-based Syntiant Corp has filed for an initial public offering to capitalize on the growing enthusiasm for semiconductors and AI technologies, although the offering size remains undisclosed.
- Listing Plans: The company intends to list its shares under the symbol “SYTN” on the Nasdaq Global Market, reflecting its confidence in the capital markets and expectations for future growth.
- Financial Performance: In Q1 2026, Syntiant reported a net loss of $20.9 million on revenues of $64.5 million, indicating a slight decline from $66.6 million in revenue a year earlier, yet showcasing its market potential.
- Investor Backing: Syntiant has garnered support from notable investors such as Intel Capital, Microsoft Global Finance, and Knowles Corp, highlighting its recognition in the industry and potential for future development.
- Funding and Valuation: SambaNova Systems has successfully raised $1 billion, achieving an $11 billion valuation, which reflects strong investor confidence in the growing demand for artificial intelligence hardware and solidifies its market position.
- Investor Backing: The funding round was led by General Atlantic, with support from Intel's venture arm, indicating significant trust and interest from major tech companies in SambaNova's future development.
- Use of Proceeds: SambaNova plans to use the funds to expand capacity, accelerate product innovation, and scale deployments for enterprises, neo-clouds, and sovereign AI customers globally, aiming to enhance its competitive edge in the market.
- Partnerships: JPMorgan Chase has selected SambaNova as its inference infrastructure partner, deploying its SN40 and SN50 systems to enable secure on-premises AI inference, further validating SambaNova's significance in the industry.
- Successful Financing: SambaNova has successfully raised $1 billion, bringing its valuation to $11 billion, with this funding round led by General Atlantic and participation from Seligman Ventures, T. Rowe Price, and Capital Group, indicating strong investor confidence in AI chip startups.
- Market Positioning: Focused on inference chips and on-premise AI deployments, SambaNova's latest SN50 chip can be deployed in data centers, contrasting sharply with Nvidia's GPU architecture, aiming to meet enterprise demands for fast and cost-effective AI model execution.
- Corporate Collaboration: JPMorgan Chase announced it will deploy SambaNova's systems for on-prem inference to meet its enterprise AI workload needs, a move that not only enhances AI security but also accelerates response times, thereby boosting corporate competitiveness.
- Industry Outlook: The successful financing of SambaNova reflects the strong demand for AI infrastructure in the booming semiconductor industry, particularly in the inference chip sector, which is expected to drive further investment and innovation among startups.
- Massive Funding Round: SambaNova Systems has raised $1 billion in its latest funding round, bringing its valuation to $11 billion, with General Atlantic leading the investment, indicating strong investor confidence in the AI chip market.
- Strategic Partnerships: Earlier this year, SambaNova secured over $350 million in funding and announced a partnership with Intel, further solidifying its position in the AI inference chip sector.
- Clear Market Positioning: The SN50 chip from SambaNova is designed for data centers to efficiently run large AI models, focusing on on-premise deployments that offer faster and more secure AI solutions, addressing enterprises' data security needs.
- Optimistic Industry Outlook: The successful funding round reflects the growing demand for AI chips in the booming semiconductor industry, particularly as enterprise AI workloads continue to increase.
- Market Pullback: Following a red-hot rally in the semiconductor sector, investors are booking profits, with Intel's stock dropping 9.7% on Tuesday, marking the largest decline in the S&P 500 index, indicating a shift in market sentiment.
- Strong Samsung Results but Stock Decline: Despite Samsung Electronics reporting a staggering 19-fold increase in expected second-quarter operating profit to 89.4 trillion won ($58.44 billion) and a 129% revenue increase to 171 trillion won, its shares fell nearly 7% in Seoul, impacting SK Hynix and the broader Kospi index.
- Broad Chip Stock Decline: In the U.S., Intel and AMD saw their stocks drop 9.7% and 6.5%, respectively, while Western Digital and SanDisk each fell over 7%, reflecting investor concerns over the AI trade losing momentum and potential broader downturns in the market.
- Analyst Insights: Despite the pullback, Daniel Newman, CEO of Futurum Group, asserts that the AI trade remains intact with demand significantly outpacing supply, suggesting that profit-taking after parabolic moves is a healthy market behavior.
- Intel Stock Plunge: Intel's stock dropped 9.7% on Tuesday, marking its steepest decline in a month and making it the biggest loser in the S&P 500, indicating that investors are booking profits after a strong rally in the semiconductor sector, which may impact the company's short-term stock performance.
- Samsung's Strong Earnings but Stock Decline: Despite Samsung Electronics reporting a staggering 19-fold increase in expected second-quarter operating profit to 89.4 trillion won ($58.44 billion) and a 129% revenue increase to 171 trillion won, its shares fell nearly 7%, reflecting market concerns over elevated valuations.
- Broad Chip Stock Retreat: In the U.S. market, AMD shares fell 6.5%, while Western Digital and SanDisk dropped over 7% each, and Micron declined 4.7%, suggesting that investor confidence in the AI trade is waning, potentially signaling a broader market pullback.
- Divergent Market Sentiment: While retail investors remain bullish on the iShares Semiconductor ETF (SOXX), sentiment towards Intel and SanDisk is neutral, and bearish for AMD and Western Digital, highlighting differing views on future semiconductor demand.











